MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria

• Fumiaki Sato ,

  * E-mail: fsato@pharm.kyoto-u.ac.jp

  Affiliation Department of Nanobio Drug Discovery, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

  ⨯
• Etsuro Hatano,

  Affiliation Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Koji Kitamura,

  Affiliation Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Akira Myomoto,

  Affiliations New Frontiers Research Laboratories, Toray Industries, Inc. Kanagawa, Japan, Department of Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

  ⨯
• Takeshi Fujiwara,

  Affiliation Department of Nanobio Drug Discovery, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

  ⨯
• Satoko Takizawa,

  Affiliation New Frontiers Research Laboratories, Toray Industries, Inc. Kanagawa, Japan

  ⨯
• Soken Tsuchiya,

  Affiliation Department of Nanobio Drug Discovery, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

  ⨯
• Gozoh Tsujimoto,

  Affiliation Department of Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

  ⨯
• Shinji Uemoto,

  Affiliation Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Kazuharu Shimizu

  Affiliation Department of Nanobio Drug Discovery, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

  ⨯